Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation

Por Halperin, Jonathan L, Dorian, Paul
Publicado em 2014

CYP2C9*8 is prevalent among African–Americans: implications for pharmacogenetic dosing

Por Scott, Stuart A, Jaremko, Malgorzata, Lubitz, Steven A, Kornreich, Ruth, Halperin, Jonathan L, Desnick, Robert J
Publicado em 2009

Association of Chronic Kidney Disease with Atrial Fibrillation Among Adults in the United States: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Por Baber, Usman, Howard, Virginia J., Halperin, Jonathan L., Soliman, Elsayed Z., Zhang, Xiao, McClellan, William, Warnock, David G., Muntner, Paul
Publicado em 2010

Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study

Por Reiffel, James A., Verma, Atul, Kowey, Peter R., Halperin, Jonathan L., Gersh, Bernard J., Wachter, Rolf, Pouliot, Erika, Ziegler, Paul D.
Publicado no JAMA Cardiol (2017)

Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study

Por Conti, Sergio, Reiffel, James A, Gersh, Bernard J, Kowey, Peter R, Wachter, Rolf, Halperin, Jonathan L, Kaplon, Rachelle E, Pouliot, Erika, Verma, Atul
Publicado no J Atr Fibrillation (2017)

Bisphosphonate use and the Prevalence of Valvular and Vascular Calcification in Women: The Multi-Ethnic Study of Atherosclerosis

Por Elmariah, Sammy, Delaney, Joseph A. C., O'Brien, Kevin D., Budoff, Matthew J., Vogel-Claussen, Jens, Fuster, Valentin, Kronmal, Richard A., Halperin, Jonathan L.
Publicado em 2010

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

Por Scott, Stuart A, Patel, Manishkumar, Martis, Suparna, Lubitz, Steven A, van der Zee, Sarina, Yoo, Chang, Edelmann, Lisa, Halperin, Jonathan L, Desnick, Robert J
Publicado em 2011

Associations of Left Ventricular Hypertrophy with Prevalent and Incident Valve Calcification: The Multi-Ethnic Study of Atherosclerosis

Por Elmariah, Sammy, Delaney, Joseph A. C., Bluemke, David A, Budoff, Matthew J., O’Brien, Kevin D., Fuster, Valentin, Kronmal, Richard A., Halperin, Jonathan L.
Publicado em 2012

Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program

Por McIntyre, William F., Conen, David, Olshansky, Brian, Halperin, Jonathan L., Hayek, Emil, Huisman, Menno V., Lip, Gregory Y.H., Lu, Shihai, Healey, Jeff S.
Publicado no Clin Cardiol (2018)

Risk Factors Associated with the Incidence and Progression of Mitral Annulus Calcification: The Multi-Ethnic Study of Atherosclerosis

Por Elmariah, Sammy, Budoff, Matthew J., Delaney, Joseph A. C., Hamirani, Yasmin, Eng, John, Fuster, Valentin, Kronmal, Richard A., Halperin, Jonathan L., O’Brien, Kevin D.
Publicado em 2013

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model

Por Goldenberg, Neil A., Spyropoulos, Alex C., Halperin, Jonathan L., Kessler, Craig M., Schulman, Sam, Turpie, Alexander G. G., Skene, Allan M., Cutler, Neal R., Hiatt, William R.
Publicado em 2011

Balancing Risk and Benefit in Venous Thromboembolism Trials: Concept for a Bivariate Endpoint Trial Design and Analytic Approach

Por Kittelson, John M., Spyropoulos, Alex C., Halperin, Jonathan L., Kessler, Craig M., Schulman, Sam, Steg, Gabriel, Turpie, Alexander G. G., Cutler, Neal R., Hiatt, William R., Goldenberg, Neil A.
Publicado no J Thromb Haemost (2013)

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial

Por Ezekowitz, Michael D, Pollack, Charles V, Halperin, Jonathan L, England, Richard D, VanPelt Nguyen, Sandra, Spahr, Judith, Sudworth, Maria, Cater, Nilo B, Breazna, Andrei, Oldgren, Jonas, Kirchhof, Paulus
Publicado no Eur Heart J (2018)

Non-Central Nervous System Systemic Embolism in Patients with Atrial Fibrillation: Results from ROCKET AF

Por Orgel, Ryan, Wojdyla, Daniel, Huberman, David, Halperin, Jonathan L., Breithardt, Günter, Singer, Daniel E., Fox, Keith A.A., Hankey, Graeme J., Mahaffey, Kenneth W., Jones, W. Schuyler, Patel, Manesh R.
Publicado no Circ Cardiovasc Qual Outcomes (2017)

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic...

Por Huisman, Menno V., Ma, Chang Sheng, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Rothman, Kenneth J., Teutsch, Christine, Schoof, Nils, Kleine, Eva, Bartels, Dorothee B., Lip, Gregory Y.H.
Publicado no Europace (2016)

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry

Por Mazurek, Michał, Huisman, Menno V., Rothman, Kenneth J., Paquette, Miney, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Ma, Chang Sheng, Zint, Kristina, Elsaesser, Amelie, Lu, Shihai, Lip, Gregory Y. H.
Publicado no Thromb Haemost (2017)

Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Por Adams, Robert J., Albers, Greg, Alberts, Mark J., Benavente, Oscar, Furie, Karen, Goldstein, Larry B., Gorelick, Philip, Halperin, Jonathan, Harbaugh, Robert, Johnston, S. Claiborne, Katzan, Irene, Kelly-Hayes, Margaret, Kenton, Edgar J., Marks, Michael, Sacco, Ralph L., Schwamm, Lee H.
Publicado em 2008

Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice G...

Por You, John J., Singer, Daniel E., Howard, Patricia A., Lane, Deirdre A., Eckman, Mark H., Fang, Margaret C., Hylek, Elaine M., Schulman, Sam, Go, Alan S., Hughes, Michael, Spencer, Frederick A., Manning, Warren J., Halperin, Jonathan L., Lip, Gregory Y. H.
Publicado em 2012

Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial

Por Singer, Daniel E., Hellkamp, Anne S., Piccini, Jonathan P., Mahaffey, Kenneth W., Lokhnygina, Yuliya, Pan, Guohua, Halperin, Jonathan L., Becker, Richard C., Breithardt, Günter, Hankey, Graeme J., Hacke, Werner, Nessel, Christopher C., Patel, Manesh R., Califf, Robert M., Fox, Keith A. A.
Publicado em 2013

Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial

Por Singer, Daniel E., Hellkamp, Anne S., Yuan, Zhong, Lokhnygina, Yuliya, Patel, Manesh R., Piccini, Jonathan P., Hankey, Graeme J., Breithardt, Günter, Halperin, Jonathan L., Becker, Richard C., Hacke, Werner, Nessel, Christopher C., Mahaffey, Kenneth W., Fox, Keith A. A., Califf, Robert M.
Publicado no J Am Heart Assoc (2015)